# Adult ADHD Diagnostic Studies and Tools

## Clinical Rating Scales and Diagnostic Interviews

1. Bakare & Jordanova (2020) - Brief screening measure development
2. Bastiaens & Galus (2018) - ASRS screener comparison DSM-IV vs DSM-5
3. Chen et al. (2021) - Machine learning ADHD classification
4. Chiasson et al. (2012) - ASRS in ADHD + substance abuse populations
5. Dakwar et al. (2012) - ADHD screening in substance use disorders
6. Dunlop et al. (2018) - ASRS in major depressive disorder
7. Eich et al. (2012) - New rating scale based on SCL-90-R
8. Erhardt et al. (1999) - Self-ratings reliability and validity
9. Faraone et al. (2000) - Symptom assessment children vs adults
10. Gift et al. (2021) - Wender Utah Rating Scale psychometrics
11. Grogan et al (2017) - CAARS, STAI (adhd and anxiety)
12. Harrison et al (2016) - CAARS
13. Houston et al. (2011) - Primary care screening instrument
14. Kessler et al. (2010) - Adult ADHD Clinical Diagnostic Scale
15. Kingston et al (2013) - Multiple measures + CPT
16. Kwan et al (2024) - CAARS
17. Lancaster et al (2018) - PAI
18. Kumar et al. (2011) - MINI, CAARS, Screening in psychiatric inpatients
19. Lewandowski et al. (2008) - College student symptom reporting
20. Liu et al. (2023) - Machine learning screening approach
21. Luderer et al. (2019) - ADHD screening in alcohol dependent patients
22. Luty et al. (2009) - Self-report validation in substance users
23. Marchant et al. (2015) - Self-Report Wender-Reimherr Scale
24. Mattos et al. (2018) - DSM criteria in medical students
25. McCann & Roy-Byrne (2004) - Self-report scales utility
26. Mehringer et al. (2002) - Assessment of Hyperactivity and Attention tool
27. Notzon et al. (2020) - CAADID, ADHD in cannabis use disorders
28. Palma-Álvarez et al. (2023) - MINI-Plus ADHD module validation
29. Palmer et al. (2023) - Screening in young autistic adults
30. Reimherr et al. (2021) - Wender Utah Rating Scale versions
31. Reyes et al. (2019) - ASRS utility in alcoholics
32. Singh et al. (2015) - IPDE screening questionnaire
33. Ustun et al. (2017) - WHO Adult ADHD Self-Report Scale
34. van de Glind et al. (2013) - ASRS in substance use disorders
35. Van Voorhees et al. (2011) - Self and other-ratings reliability
36. Vitola et al. (2017) - DSM-5 criteria exploration
37. Vizgaitis et al. (2023) - Self-reported symptoms analysis
38. Young et al. (2016) - BAARS-IV, Prison inmate screening tool
39. Young et al. (2005) - YAQ-S and YAQ-I symptomatology
40. Young et al. (2023) - ASSET-BS screening measure development
41. Groom et al (2016) - CAARS + QB Test, ADHD vs. Autism

## Neuropsychological and Cognitive Tests

1. Adamou et al (2022) - Qb Test
2. Brunkhorst-Kanaan (2020) - QB Test
3. Cohen & Shapiro (2007) - Flicker task and CPT comparison
4. Edebol et al (2012) - QB Test, ADHD, Bipolar, Borderline PD
5. Edebol et al (2013) - QB Test
6.  Elbaum et al. (2020) - MOXO-dCPT with eye tracking
7. Emser et al. (2018) - TAP, QB Test (child and adult), CAARS, Conners-3
   (child) **(exclude?)**
8. Kovner et al. (1998) - Neuropsychological testing pilot study; multiple tests
9.  Lee Booksh et al. (2010) - Attention measures in college students; multiple tests
10. Lev et al. (2022) - MOXO-dCPT with eye tracking
11. Lovejoy et al. (1999) - Executive function measures (multiple)
12. Mostert et al. (2015) - DIVA + multiple neuropsychological tests
13. Nielsen & Wiig (2011) - A Quick Test of Cognitive Speed (AQT)
14. Paucke et al. (2021) - Go/NoGo + WURS + CAARS
15. Pettersson et al. (2018) - (DIVA 2.0 + ASRS) vs 8 neuropsychological tests
16. Schreiber et al. (1999) - Rey-Osterrieth Complex Figure validation
17. Shepler & Callan (2024) - Executive functioning differences
18. Söderström et al. (2014) - QB Test + ASRS
19. Solanto et al. (2004) - (WURS, CAARS, Brown ADD for dx) Conners CPT
20. Unal et al. (2019) - Stroop test, Stroop Plus, and Perceptual
Selectivity test
1.  Wiig & Nielsen (2012) - A Quick Test of Cognitive Speed (AQT)
2.  Woods et al. (2002) - Multiple neuropsych tests

## Neuroimaging Studies

1. Chaim-Avancini et al. (2017) - T1-weighted MRI and DTI
1. Amen et al. (2021) - SPECT
1. Schneider et al. (2014) - SPECT
1. Wang et al. (2013) - ReHo rs-fMRI
1. Wang et al. (2023) - ReHo rs-fMRI
1. Wolfers et al. (2016) - fMRI Stop-Signal Task
1. Yao et al. (2018) - rs-fMRI
1. Alves et al. (2023) - rs-fMRI <!--ASD, ADHD, controls -->

## EEG/Electrophysiological Studies

1. Biederman et al (2017) - Brain Network Activation (BNA) of EEG data during
   Go/NoGo task
1. Hadas et al. (2021) - TMS evoked potentials (TEPs)
1. Kaur et al. (2020) - EEG phase space reconstruction during CPT
1. Kiiski et al. (2020) - Functional EEG connectivity
4. Kim et al. (2021) - Machine learning mismatch negativity
5. Mueller et al. (2011) - ERP components discrimination
6. Müller et al. (2020) - EEG/ERP biomarkers
7.  Poil et al. (2014) - Age-dependent EEG changes (**children included?**)
8.  Ponomarev et al. (2014) - Group ICA and current source density
9.  Shahaf et al. (2012) - Network oriented ERP analysis

## Performance Validity/Effort Testing/Symptom Exaggeration


### Performance-based 'embedded' validity indicators

1. Becke et al (2023) - WURS-K, ADHS-SB, TOMM, Neuropsych Battery
2. Berger et al (2021) - MOXO-d-CPT
3. Finley et al. (2023) - Stroop, TMT, Verbal Fluency, WAIS-IV
4. Khan et al. (2022) - Stroop
5. Robinson et al. (2023) - CPT-3, Multiple PVT's
6. Harrison and Armstrong (2020) - MSVT, TOVA
7. Rogers et al. (2021) - WAIS-IV
8. Phillips et al. (2023) - BVMT-R, RAVLT
9. Spenceley et al. (2022) - WJ-IV

### Performance-based 'standalone' validity indicators

1. Morey (2019) - TOAD
1. Abramson et al (2023) - DCT
1. Fuermaier et al (2016) - EFT

### Rating scales for symptom exaggeration

1. Aita et al. (2018) - PAI, 
1. Smith et al. (2017) - PAI feigning detection
1. Young & Gross (2011) - MMPI-2
1. Cook et al. (2016) - Conners' Infrequency Index validation
1. Courrégé et al. (2019) - ADHD Symptom Infrequency Scale
1. Finley et al (2024) - Clinical Assessment of Attention Deficit–Adult
1. Harrison & Armstrong (2016) - Exaggeration Index (EI)
1. Harrison et al. (2022) - PAI validity measures
1. Musso et al. (2016) - PAI utility
1. Potts et al. (2022) - Multidimensional ADHD Rating Scale
1. Ramachandran et al. (2019) - Subtle ADHD Malingering Screener
 
### Combined neurocognitive effort test(s) and rating scale(s)

1. Sollman et al. (2010) - CAARS + TOMM, LMT, NVMST
1. Quinn (2003) - ADHD Behavior Checklist, IVA-CPT
1. Marshall et al. (2010) - Barkley RS, CAT-A, WMT, b Test, DCT, TOVA
1. Harrison et al (2007) - CAARS, WJ-III
1. Williamson et al. (2014) - TOMM, DMT, LMT, NV-MSVT, b Test, WAIS-IV, WJ-III

## Biomarkers

1. Andrikopoulos et al. (2024) - Machine learning with physiological data
2. Grünblatt et al. (2012) - Transcription markers in whole blood
3. Jiminez et al (2021) - Eye vergence/oculomotor
4. Juselius Baghdassarian et al. (2018) - Auditory brainstem response (ABR)
5. Selek et al. (2012) - Total Antioxidative Status (TAS), Total
Oxidative Status (TOS), and Oxidative Stress Index (OSI)
1. Udal et al. (2024) - Neuromuscular assessment
2. Woodruff et al. (2011) - A new blood test that measures blood cell membrane
potential (expressed as membrane potential ratio [MPRTM])
